摘要
目的:观察中药肺复康方治疗中晚期肺鳞癌的疗效。方法:将81例患者随机分为两组。对照组单纯对症支持疗,治疗组单纯采用中药肺复康方治疗。观察靶病灶控制情况、生活质量变化免疫功能等。结果:两组临床获益率(CR+PR+SD)/n×100%比较,治疗组为68.29%明显高于对照组36.58%。治疗后生活质量改善有效率比较,治疗组为75.61%明显高于对照组51.22%。两组治疗后免疫功能变化比较,在NK、IL-2、CD4+/CD8+等方面,差异均有非常显著性意义,治疗组优于对照组。结论:单纯中药肺复康方治疗中晚期肺鳞癌的疗效优于单纯对症支持治疗。
Objective To observe the curative effect of Feifu Kang in the treatment of advanced squamous cell lung cancer. Methods 81 patients with advanced cancer were allocated to two groups randomly. The patients in control group were only given supportive treatment according to the symptom. The patients in treatment group were given pure traditional Chinese medicine with Feifu Kang. The size of the primary lesion,living quality and immune function were observed. Results Comparing the clinical benefit rate of the primary lesion( CR + PR + SD) /n × 100%,the treatment group was 68. 29%,the control group was 36. 58%,the different was very significant.Comparing the efficiency of improved living quality after treatment,the treatment group was 75. 61%,the control group was 51. 22%,the different was significant. Comparing immune function after treatment,in the aspects of NK,IL-2,CD4+/CD8+,the difference was very significant,the treatment group was better than the control group.Conclusion The curative effect of pure traditional Chinese medicine with Feifu Kang was better than supportive treatment according to the symptom alone.
出处
《湖南师范大学学报（医学版）》
2014年第2期30-32,共3页
Journal of Hunan Normal University(Medical Sciences)
基金
湖南省中医药管理局重点课题(2010006)
关键词
肺鳞癌
肺复康方
squamous cell lung cancer
Feifu Kang
